Status Active Distribution Worldwide Founded 2003 | Country of origin United Kingdom Key people Tim Hill, Publisher Number of employees 50 | |
 | ||
Profiles | ||
Dove Medical Press is an academic publisher of open access peer-reviewed scientific and medical journals, with offices in Manchester, London (United Kingdom), Princeton, New Jersey (United States), and Auckland (New Zealand).
Contents
- Video s1 2014 skopalik et al publisher and licensee dove medical press ltd
- History
- Copyright
- References
The executive directors are Philip Smith and Kevin Toale.
As an open access publisher, Dove charges a publication fee to authors or their institutions or funders. This charge allows Dove to recover its editorial and production costs and to create a pool of funds that can be used to provide fee waivers for authors from lesser developed countries. Articles published are available via an interface following the Open Archives Initiative Protocol for Metadata Harvesting, a set of uniform standards promulgated by the Open Archives Initiative allowing metadata on archive holdings.
Dove is a member of the Association of Learned and Professional Society Publishers, the Committee on Publication Ethics, and the Open Archives Initiative. As of April 2013, it publishes 131 journals.
Video s1 2014 skopalik et al publisher and licensee dove medical press ltd
History
Dove Medical Press is a privately held company founded in 2003 by Tim Hill, a former managing director of Adis International and five other founders.
As of 11 April 2013, 42 of the 131 journals were indexed in PubMed, while 30 of the 131 journals had fewer than 10 articles. In 2012, the company was included on Beall's list of predatory open access publishers, but was later removed.
Dove Medical Press is a member and sponsor for multiple professional organizations. They also support scientific dissemination by sponsoring events such as the annual International Translational Nanomedicine conference (ITNano) started in 2013, and awards such as the Distinguished Career, and the Young Scholar Awards, presented by one of their journals, the International Journal of Nanomedicine (IJN).
In 2012, Dove Medical Press became carbon neutral, obtaining carboNZero programme certification.
In 2013, the Dove Medical Press journal Drug Design, Development and Therapy accepted a false and intentionally flawed paper created and submitted by an investigative journalist for Science as part of a "sting" to test the effectiveness of the peer-review processes of open access journals (Who's Afraid of Peer Review?). The Open Access Scholarly Publishers Association terminated Dove's membership as a result of the incident. After satisfying The Open Access Scholarly Publishers Association Membership Committee that new editorial and peer review procedures were in place to address the concerns raised during its investigation, Dove Medical Press was reinstated as a full member of Open Access Scholarly Publishers Association in September 2015.
Copyright
All articles, including meta-data and supplementary files, are published under the Creative Commons Attribution license.